The What, Why, and How of Anti-PD-1/PD-L1 Immunotherapy for Cancer

The immune system is responsible for the recognition and clearance of malignant cells from the human body. This process involves a multitude of tightly controlled processes that allow actions to be taken on aberrant cells yet spares the normal functioning of tissues. Immunotherapy refers to a class of medications and therapy modalities responsible for utilizing certain small molecules or receptors already involved in the immune system cascade or mimicking their actions. Once activated or reactivated, the immune system can target clinical cancerous lesions. This program will highlight immunotherapy history and mechanisms employed in the aid of cancer eradication from the human body. FDA approved immunotherapy agents will be described including their mechanisms, indications for use, adverse event profile, and use in combination therapy. Future horizons of immunotherapeutic agents will be briefly reviewed. Sign up for this course at the link below! ----------------------------------------------------------------------------------------------- Learn more about freeCE: Webinar Sign Up: https://www.freece.com/Events/Calenda... Website: https://www.freece.com/ Webcasts: https://www.freece.com/Home/CECataLog... Facebook -   / freeceonline   Twitter -   / freeceonline   Instagram -   / freeceonline    LinkedIn -   / freece---a-subsidiary-of-pharmcon   ----------------------------------------------------------------------------------------------- #freeCE #continuingeducation #pharmacy